MAS vs TNGX · P/E 18, rev $7.56B vs $5.36B cap
Masco Corporation (MAS) versus Tango Therapeutics Inc (TNGX) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. TNGX currently screens at market cap $5.36B.
Not investment advice. Open the MAS and TNGX stock pages for the full models.
Not investment advice.